Literature DB >> 15755988

AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers.

Trevor M Penning1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15755988     DOI: 10.1158/1078-0432.CCR-05-0071

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  33 in total

1.  Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals.

Authors:  Rui Wang; Guoqing Wang; Megan J Ricard; Barbara Ferris; Yael Strulovici-Barel; Jacqueline Salit; Neil R Hackett; Lorraine J Gudas; Ronald G Crystal
Journal:  Chest       Date:  2010-08-12       Impact factor: 9.410

Review 2.  [Role of transcription factor AP-1 in integration of cellular signalling systems].

Authors:  K T Turpaev
Journal:  Mol Biol (Mosk)       Date:  2006 Nov-Dec

3.  Impact of smoking cessation on global gene expression in the bronchial epithelium of chronic smokers.

Authors:  Li Zhang; J Jack Lee; Hongli Tang; You-Hong Fan; Lianchun Xiao; Hening Ren; Jonathan Kurie; Rodolfo C Morice; Waun Ki Hong; Li Mao
Journal:  Cancer Prev Res (Phila)       Date:  2008-03-31

4.  Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Authors:  Kristina A Matkowskyj; Han Bai; Jie Liao; Wanying Zhang; Haonan Li; Sambasiva Rao; Reed Omary; Guang-Yu Yang
Journal:  Hum Pathol       Date:  2013-12-18       Impact factor: 3.466

5.  Comparative functional analysis of human medium-chain dehydrogenases, short-chain dehydrogenases/reductases and aldo-keto reductases with retinoids.

Authors:  Oriol Gallego; Olga V Belyaeva; Sergio Porté; F Xavier Ruiz; Anton V Stetsenko; Elena V Shabrova; Natalia V Kostereva; Jaume Farrés; Xavier Parés; Natalia Y Kedishvili
Journal:  Biochem J       Date:  2006-10-01       Impact factor: 3.857

6.  Carboplatin-gemcitabine combination chemotherapy upregulates AKR1B10 expression in bladder cancer.

Authors:  Yasuhiro Hashimoto; Kengo Imanishi; Noriko Tokui; Teppei Okamoto; Akiko Okamoto; Shingo Hatakeyama; Takahiro Yoneyama; Takuya Koie; Noritaka Kamimura; Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2011-12-27       Impact factor: 3.402

7.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

8.  Sulindac inhibits pancreatic carcinogenesis in LSL-KrasG12D-LSL-Trp53R172H-Pdx-1-Cre mice via suppressing aldo-keto reductase family 1B10 (AKR1B10).

Authors:  Haonan Li; Allison L Yang; Yeon Tae Chung; Wanying Zhang; Jie Liao; Guang-Yu Yang
Journal:  Carcinogenesis       Date:  2013-05-20       Impact factor: 4.944

9.  The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance.

Authors:  Jong-Heum Park; Stacy Gelhaus; Srilakshmi Vedantam; Andrea L Oliva; Abhita Batra; Ian A Blair; Andrea B Troxel; Jeffrey Field; Trevor M Penning
Journal:  Chem Res Toxicol       Date:  2008-05       Impact factor: 3.739

10.  Aldo-keto reductase family 1 member B10 promotes cell survival by regulating lipid synthesis and eliminating carbonyls.

Authors:  Chun Wang; Ruilan Yan; Dixian Luo; Kounosuke Watabe; Duan-Fang Liao; Deliang Cao
Journal:  J Biol Chem       Date:  2009-07-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.